159 related articles for article (PubMed ID: 26013768)
1. Comparison of cumulative false-positive risk of screening mammography in the United States and Denmark.
Kemp Jacobsen K; Abraham L; Buist DS; Hubbard RA; O'Meara ES; Sprague BL; Kerlikowske K; Vejborg I; Von Euler-Chelpin M; Njor SH
Cancer Epidemiol; 2015 Aug; 39(4):656-63. PubMed ID: 26013768
[TBL] [Abstract][Full Text] [Related]
2. Comparing sensitivity and specificity of screening mammography in the United States and Denmark.
Kemp Jacobsen K; O'Meara ES; Key D; S M Buist D; Kerlikowske K; Vejborg I; Sprague BL; Lynge E; von Euler-Chelpin M
Int J Cancer; 2015 Nov; 137(9):2198-207. PubMed ID: 25944711
[TBL] [Abstract][Full Text] [Related]
3. Predicting the risk of a false-positive test for women following a mammography screening programme.
Njor SH; Olsen AH; Schwartz W; Vejborg I; Lynge E
J Med Screen; 2007; 14(2):94-7. PubMed ID: 17626709
[TBL] [Abstract][Full Text] [Related]
4. Mammographic screening interval in relation to tumor characteristics and false-positive risk by race/ethnicity and age.
O'Meara ES; Zhu W; Hubbard RA; Braithwaite D; Kerlikowske K; Dittus KL; Geller B; Wernli KJ; Miglioretti DL
Cancer; 2013 Nov; 119(22):3959-67. PubMed ID: 24037812
[TBL] [Abstract][Full Text] [Related]
5. The cumulative risk of false-positive results in the Norwegian Breast Cancer Screening Program: updated results.
Roman M; Hubbard RA; Sebuodegard S; Miglioretti DL; Castells X; Hofvind S
Cancer; 2013 Nov; 119(22):3952-8. PubMed ID: 23963877
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy.
Kerlikowske K; Zhu W; Hubbard RA; Geller B; Dittus K; Braithwaite D; Wernli KJ; Miglioretti DL; O'Meara ES;
JAMA Intern Med; 2013 May; 173(9):807-16. PubMed ID: 23552817
[TBL] [Abstract][Full Text] [Related]
7. Statistical Methods for Estimating the Cumulative Risk of Screening Mammography Outcomes.
Hubbard RA; Ripping TM; Chubak J; Broeders MJ; Miglioretti DL
Cancer Epidemiol Biomarkers Prev; 2016 Mar; 25(3):513-20. PubMed ID: 26721668
[TBL] [Abstract][Full Text] [Related]
8. Toward the breast screening balance sheet: cumulative risk of false positives for annual versus biennial mammograms commencing at age 40 or 50.
Winch CJ; Sherman KA; Boyages J
Breast Cancer Res Treat; 2015 Jan; 149(1):211-21. PubMed ID: 25476499
[TBL] [Abstract][Full Text] [Related]
9. Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies.
Mandelblatt JS; Stout NK; Schechter CB; van den Broek JJ; Miglioretti DL; Krapcho M; Trentham-Dietz A; Munoz D; Lee SJ; Berry DA; van Ravesteyn NT; Alagoz O; Kerlikowske K; Tosteson AN; Near AM; Hoeffken A; Chang Y; Heijnsdijk EA; Chisholm G; Huang X; Huang H; Ergun MA; Gangnon R; Sprague BL; Plevritis S; Feuer E; de Koning HJ; Cronin KA
Ann Intern Med; 2016 Feb; 164(4):215-25. PubMed ID: 26756606
[TBL] [Abstract][Full Text] [Related]
10. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
Lynge E
APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
[TBL] [Abstract][Full Text] [Related]
11. Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates?
Braithwaite D; Zhu W; Hubbard RA; O'Meara ES; Miglioretti DL; Geller B; Dittus K; Moore D; Wernli KJ; Mandelblatt J; Kerlikowske K;
J Natl Cancer Inst; 2013 Mar; 105(5):334-41. PubMed ID: 23385442
[TBL] [Abstract][Full Text] [Related]
12. Risk of breast cancer after false-positive test results in screening mammography.
von Euler-Chelpin M; Risør LM; Thorsted BL; Vejborg I
J Natl Cancer Inst; 2012 May; 104(9):682-9. PubMed ID: 22491228
[TBL] [Abstract][Full Text] [Related]
13. Is mammography screening history a predictor of future breast cancer risk?
Andersen SB; Törnberg S; Kilpeläinen S; Von Euler-Chelpin M; Njor SH
Eur J Epidemiol; 2015 Feb; 30(2):143-9. PubMed ID: 25421784
[TBL] [Abstract][Full Text] [Related]
14. Likelihood of early detection of breast cancer in relation to false-positive risk in life-time mammographic screening: population-based cohort study.
Otten JDM; Fracheboud J; den Heeten GJ; Otto SJ; Holland R; de Koning HJ; Broeders MJM; Verbeek ALM
Ann Oncol; 2013 Oct; 24(10):2501-2506. PubMed ID: 23788759
[TBL] [Abstract][Full Text] [Related]
15. Risk of breast cancer after false-positive results in mammographic screening.
Román M; Castells X; Hofvind S; von Euler-Chelpin M
Cancer Med; 2016 Jun; 5(6):1298-306. PubMed ID: 26916154
[TBL] [Abstract][Full Text] [Related]
16. Benefits and Harms of Breast Cancer Screening: A Systematic Review.
Myers ER; Moorman P; Gierisch JM; Havrilesky LJ; Grimm LJ; Ghate S; Davidson B; Mongtomery RC; Crowley MJ; McCrory DC; Kendrick A; Sanders GD
JAMA; 2015 Oct; 314(15):1615-34. PubMed ID: 26501537
[TBL] [Abstract][Full Text] [Related]
17. Predicting the cumulative risk of false-positive mammograms.
Christiansen CL; Wang F; Barton MB; Kreuter W; Elmore JG; Gelfand AE; Fletcher SW
J Natl Cancer Inst; 2000 Oct; 92(20):1657-66. PubMed ID: 11036111
[TBL] [Abstract][Full Text] [Related]
18. Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study.
Hubbard RA; Kerlikowske K; Flowers CI; Yankaskas BC; Zhu W; Miglioretti DL
Ann Intern Med; 2011 Oct; 155(8):481-92. PubMed ID: 22007042
[TBL] [Abstract][Full Text] [Related]
19. Overdiagnosis in screening mammography in Denmark: population based cohort study.
Njor SH; Olsen AH; Blichert-Toft M; Schwartz W; Vejborg I; Lynge E
BMJ; 2013 Feb; 346():f1064. PubMed ID: 23444414
[TBL] [Abstract][Full Text] [Related]
20. Balancing sensitivity and specificity: sixteen year's of experience from the mammography screening programme in Copenhagen, Denmark.
Utzon-Frank N; Vejborg I; von Euler-Chelpin M; Lynge E
Cancer Epidemiol; 2011 Oct; 35(5):393-8. PubMed ID: 21239242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
